DMK PHARMACEUTICALS CORPORATION Inventory Recall Expense
DMK PHARMACEUTICALS CORPORATION reported Inventory Recall Expense of $2.60 million for the 18-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryRecallExpense · last filed 2023-11-14
- DMK PHARMACEUTICALS CORPORATION inventory recall expense for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- DMK PHARMACEUTICALS CORPORATION inventory recall expense for the quarter ending 2023-06-30 was $0.00.
- DMK PHARMACEUTICALS CORPORATION inventory recall expense for the quarter ending 2022-09-30 was $388.00K.
- DMK PHARMACEUTICALS CORPORATION inventory recall expense for the quarter ending 2022-06-30 was $0.00.
- DMK PHARMACEUTICALS CORPORATION inventory recall expense for fiscal 2021 was $2.00M.
| Period end | Inventory Recall Expense 0 month | Inventory Recall Expense 3 month | Inventory Recall Expense 6 month | Inventory Recall Expense 9 month | Inventory Recall Expense 12 month | Inventory Recall Expense 15 month | Inventory Recall Expense 18 month | Inventory Recall Expense 24 month |
|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 18 month − 10-Q 15 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $2.60M 10-Q · filed 2023-11-14 | |||||
| 2023-06-30 | $0.00 derived: 10-Q 15 month − 10-Q 12 month · filed 2023-08-21 | $2.60M 10-Q · filed 2023-08-21 | ||||||
| 2023-03-31 | $2.60M 10-Q · filed 2023-05-15 | |||||||
| 2022-12-31 | $2.50M 10-K · filed 2023-03-16 | |||||||
| 2022-09-30 | $388.00K 10-Q · filed 2022-11-14 | $2.40M 10-Q · filed 2022-11-14 | $2.39M derived: sum of 3 quarters · filed 2022-11-14 | |||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $2.00M 10-Q · filed 2022-08-10 | ||||||
| 2022-03-31 | $2.00M 10-Q · filed 2022-05-16 | |||||||
| 2022-03-21 | $2.00M 10-Q · filed 2023-08-21 | |||||||
| 2021-12-31 | $2.00M 10-K · filed 2023-03-16 |